MANTOVANI, GIOVANNI
MANTOVANI, GIOVANNI
[p55 and p75 subunits of the IL 2 receptor, membrane bound and soluble, in peripheral lymphocytes in patients with solid tumors]
1993-01-01 Mantovani, G; Macciò, Antonio; Contini, L; Esu, S; Littera, S; Lai, P; Proto, E; Balestrieri, A; Del Giacco, G S
[The immunological assessment of a combined therapeutic approach (chemo- + radiotherapy +/- surgery) including immunotherapy in neoplasms of the head and neck area at an advanced stage]
1995-01-01 Mantovani, G; Ghiani, M; Bianchi, A; Curreli, L; Contini, L; Macciò, Antonio; Santona, M C; Proto, E; Cossu, F; Puxeddu, P
A phase II study with antioxidants, both in the diet an supplemented, pharmaco-nutritional support, progestagen and anti-COX-2 showing efficacy and safety in patients with cancer-related anorexia-cachexia and oxidative stress
2006-01-01 Mantovani, G; Madeddu, Clelia; Macciò, A; Gramignano, G; Lusso, Mr; Massa, E; Astara, G; Serpe, R.
Advances in pharmacologic strategies for cancer cachexia
2015-01-01 Madeddu, Clelia; Mantovani, Giovanni; Gramignano, G; Macciò, A.
An innovative treatment approach for cancer-related anorexia/cachexia and oxidative stress: Background and design of an ongoing, phase III, randomized clinical trial
2007-01-01 Mantovani, G.; Madeddu, C.; Gramignano, G.; Serpe, R.; Massa, E.; Deiana, L.; Maccio, A.
Anorexia/Cachexia and oxidative stress in cancer patients = Anoressia/Cachessia e stress ossidativo nei pazienti con cancro
2003-01-01 Mantovani, G; Macciò, A; Madeddu, Clelia; Mura, L; Massa, E; Astara, G; Gramignano, G; Lusso, Mr; Murgia, V; Camboni, P; Ferreli, L.
Assessment of the efficacy of two dosages and schedules of human recombinant erythropoietin in the prevention and correction of cisplatin-induced anemia in cancer patients
1999-01-01 Mantovani, G; Ghiani, M; Curreli, L; Maccio, A; Massa, D; Succu, G; Lai, P; Massa, Elena; Mudu, Mc; Astara, G.
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial
2009-01-01 Rabaglio, M; Sun, Z; Price, Kn; Castiglione-Gertsch, M; Hawle, H; Thürlimann, B; Mouridsen, H; Campone, M; Forbes, Jf; Paridaens, Rj; Colleoni, M; Pienkowski, T; Nogaret, Jm; Láng, I; Smith, I; Gelber, Rd; Goldhirsch, A; Coates, As; Mantovani, G; Massa, E; on behalf of BIG 1-98 Collaborative and International Breast Cancer Study, Groups.
Cisplatin induces serotonin release from human peripheral blood mononuclear cells of cancer patients and methylprednisolone inhibits this effect
1997-01-01 Mantovani, G; Maccio, A; Massa, Elena; Lai, P; Esu, S.
Clinical and immunological evaluation of schizophyllan (SPG) in combination with standard chemotherapy in patients with head and neck squamous cell carcinoma
1997-01-01 Mantovani, G; Bianchi, A; Curreli, L; Ghiani, M; Astara, G; Lampis, B; Santona, M; Dessi, D; Esu, S; Lai, P; Massa, Elena; Maccio, A; Proto, E.
Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial
1996-01-01 Mantovani, G; Macciò, Antonio; Bianchi, A; Curreli, L; Ghiani, M; Proto, E; Santona, M C
Comparison of oral 5-HT3-receptor antagonists and low-dose oral metoclopramide plus i.m. dexamethasone for the prevention of delayed emesis in head and neck cancer patients receiving high-dose cisplatin
1998-01-01 Mantovani, G.; Macciò, A; Curreli, L; Lampis, B; Ghiani, M; Bianchi, A; Contu, P
Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate
1998-01-01 Mantovani, G; Macciò, A; Lai, P; Massa, Elena; Ghiani, M; Santona, M. C.
Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer
2009-01-01 Giobbie-Hurder, A; Price, Kn; Gelber, Rd; Mantovani, G; Massa, E; on behalf of International Breast Cancer Study, Group; BIG 1-98 Collaborative Group. Clin Trials., 2009 Jun; 6(3):272-87,
Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: a phase II study of the Southern Italy Cooperative Oncology Group (SICOG)
2001-01-01 Caponigro, F; Massa, Elena; Manzione, L; Rosati, G; Biglietto, M; De Lucia, L; Sguotti, C; Sganga, P; Avallone, A; Comella, P; Mantovani, G; Comella, G.
Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer
2002-01-01 Mantovani, G; Macciò, A; Mulas, C; Massa, Elena; Madeddu, Clelia; Mura, L; Contu, Paolo; Versace, R.
Efficacy, compliance and prognostic significance of a comprehensive geriatric assessment in the geriatric cancer patient = Efficacia, applicabilità e significato prognostico di una valutazione geriatrica multidimensionale nel paziente oncologico anziano
2003-01-01 Mantovani, G; Massa, Elena; Ferreli, L; Astara, G; Madeddu, Clelia; Gramignano, G; Lusso, M. R.
Evidence that granulosa cells inhibit interleukin-1α and interleukin-2 production from follicular lymphomonocytes
1993-01-01 Maccio, Antonio; Mantovani, G.; Turnu, E.; Artini, P.; Contu, G.; Serri, F. G.; Volpe, A.
Immunologic assessment determined by response to IL-2 and immunophenotyping of tumor-infiltrating lymphocytes, of invaded and non invaded lymph nodes and of peripheral blood lymphocytes from twenty-one patients with primary laryngeal cancer
1989-01-01 Mantovani, G; Maccio, Antonio; Zucca, M V; Serra, M C; Proto, E; Locci, F; Arangino, V; Manduco, D; Sulis, G; Puxeddu, P
Immunotherapy (recombinant interleukin 2), hormone therapy (medroxyprogesterone acetate) and antioxidant agents as combined maintenance treatment of responders to previous chemotherapy
2001-01-01 Mantovani, G; Maccio, A; Madeddu, Clelia; Massa, Elena; Mudu M., C; Mulas, C; Gramignano, G; Massidda, S; Murgia, V; Lusso M., R; Mura, L.